This finding is consistent with previous reports that when administered along with weak vaccines, IL-1β mediates enhanced immunogenicity and protection in several models of bacterial and viral infection, possibly through its capacity to augment T cell expansion and effector function [38,39]. Here, IL1B is linked to viral infectious disease.